Comparative safety of benzodiazepines and opioids among veterans affairs patients with posttraumatic stress disorder

Journal of Addiction Medicine

Volumn 7, Issue 5, 2013, Pages 354-362

  Hawkins, Eric J ^a   Malte, Carol A ^a   Grossbard, Joel ^a   Saxon, Andrew J ^a   Imel, Zac E ^a   Kivlahan, Daniel R ^a  

^a Puget Sound Health Care System   (United States)

Author keywords

Adverse events; Antidepressants; Benzodiazepines; Opioids; Posttraumatic stress disorder

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NARCOTIC ANALGESIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT; VETERAN;

ADULT; ANALGESICS, OPIOID; BENZODIAZEPINES; DRUG INTERACTIONS; DRUG MONITORING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERANS; VETERANS HEALTH;

EID: 84887949257     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31829e3957     Document Type: Article

References (34)

1. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999;319(7223):1492-1495
2. Barker MJ, Greenwood KM, Jackson M, et al. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004;18(1):37-48
3. Boscarino JA. Posttraumatic stress disorder and mortality among U.S. Army veterans 30 years after military service. Ann Epidemiol 2006;16(4):248-256
4. Braden JB, Russo J, Fan MY, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170(16):1425-1432
5. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383
6. Coben JH, Davis SM, Furbee PM, et al. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med 2010;38(5):517-524
7. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152(2):85-92
8. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300(22):2613-2620
9. Hawkins EJ, Malte CA, Imel ZE, et al. Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010. Drug Alcohol Depend 2012;124(1/2):154-161
10. Hoffman EJ, Mathew SJ. Anxiety disorders: a comprehensive review of pharmacotherapies. Mt Sinai J Med 2008;75:248-262
11. Huang AR, Mallet L, Rochefort CM, et al. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 2012;29(5):359-376
12. Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001;158(8):1184-1190
13. Keane TM, Kaloupek DG. Comorbid psychiatric disorders in PTSD. Implications for research. Ann N Y Acad Sci 1997;821:24-34
14. Kressin NR, Chang BH, Hendricks A, et al. Agreement between administrative data and patients' self-reports of race/ethnicity. Am J Public Health 2003;93(10):1734-1739
15. Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA 2011;306(5):493-502
16. Leslie DL, Mohamed S, Rosenheck RA. Off-label use of antipsychotic medications in the Department of Veterans Affairs health care system. Psychiatr Serv 2009;60(9):1175-1181
17. Lund BC, Bernardy NC, Alexander B, et al. Declining benzodiazepine use in veterans with posttraumatic stress disorder. J Clin Psychiatry 2012;73(3):292-296
18. Macey TA, Morasco BJ, Duckart JP, et al. Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain. Pain Med 2011;12(10):1502-1509
19. The Management of Post-traumatic Stress Working Group, 2010. VA/DOD Clinical Practice Guideline for Management of Post-Traumatic Stress (Version 2.0). Washington, DC: Department of Veterans Affairs and the Department of Defense. Available at http://www.healthquality.va.gov/post-traumatic-stress- disorder-ptsd.asp. Accessed April 12, 2012
20. Mohamed S, Rosenheck RA. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. J Clin Psychiatry 2008;69(6):959-965
21. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;(1):CD006605
22. Ried LD, Jia H, Feng H, et al. Selective serotonin reuptake inhibitor treatment and depression are associated with poststrokemortality. Ann Pharmacother 2011;45(7/8):888-897
23. Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009;13(3):205-214
24. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012;307(9):940-947
25. Smink BE, Egberts AC, Lusthof KJ, et al. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs 2010;24(8):639-653
26. Sox HC, Goodman SN. The methods of comparative effectiveness research. Annu Rev Public Health 2012;33:425-445
27. StataCorp. Stata Statistical Software: Release Edition 9.0. College Station, TX: Stata Corporation, 2007
28. Sullivan MD, Edlund MJ, Fan MY, et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008;138(2): 440-449
29. Takkouche B, Montes-Martinez A, Gill SS, et al. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 2007;30(2):171-184
30. Voaklander DC, Rowe BH, Dryden DM, et al. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health 2008;62(2):138-146
31. Warner M, Chen LH,Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief 2009;22: 1-8
32. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999;94(7):961-972
33. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009;169(21):1952-1960
34. Zhu HP, Xia X, Yu CH, et al. Application of Weibull model for survival of patients with gastric cancer. BMC Gastroenterol 2011;11:1